Pharmaceutical Company Protects Product in ANDA Litigation

A pharmaceutical company successfully protected one of its products in a patent infringement abbreviated new drug application (ANDA) lawsuit against defendants for their anticipated marketing of a generic version of a drug. Alison Baldwin led the litigation team that represented the pharmaceutical company in the matter, succeeding both in district court and on appeal.

The Faegre Drinker Biddle & Reath LLP website uses cookies to make your browsing experience as useful as possible. In order to have the full site experience, keep cookies enabled on your web browser. By browsing our site with cookies enabled, you are agreeing to their use. Review Faegre Drinker Biddle & Reath LLP's cookies information for more details.